Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells
Crossref DOI link: https://doi.org/10.1007/s13277-016-4868-6
Published Online: 2016-02-01
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhijun, Huang
Shusheng, Wang
Han, Min
Jianping, Li
Li-sen, Qin
Dechun, Li
Funding for this research was provided by:
National Natural Science Foundation of China
Text and Data Mining valid from 2016-02-01